[ATRA] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ATRA] Atara Biotherapeutics, Inc.
Announcement Date
28-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 13.39%
YoY- 18.94%
Quarter Report
ATRA's Result
ATRA's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 4,252 221 7,548 358,192 0 0 0 -
PBT -60,439 -74,570 -93,319 -81,299 -78,484 -80,059 -35,329 9.35%
Tax 11 2 30 8 12 -47 -16 -
NP -604,500 -745,720 -933,490 -813,070 -784,960 -800,120 -353,130 9.36%
Tax Rate - - - - - - - -
Total Cost 608,752 745,941 941,038 1,171,262 784,960 800,120 353,130 9.49%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -14,216.84 -337,429.86 -1,236.74 -22.70 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -13.98 -18.07 -23.96 -23.83 -34.03 -43.70 -28.80 -11.34%
EPS Diluted -13.98 -18.07 -23.96 -23.83 -34.03 -43.70 -28.80 -11.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.